Structural and functional relationships of toyocamycin on NPM-translocation

Anti-Cancer Drug Design

Volumn 12, Issue 3, 1997, Pages 205-215

  Finch, Rick A ^a   Revankar, Ganapathi R ^b   Chan, Pui K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Antigenics Inc   (United States)

Author keywords

B23; NPM translocation; Nucleophosmin; Toyocamycin

Indexed keywords

ADENINE; ANTINEOPLASTIC ANTIBIOTIC; FLUOROURIDINE; GUANINE; NUCLEOPHOSMIN; PYRROLO[2,3 D]PYRIMIDINE DERIVATIVE; RNA; SANGIVAMYCIN; TOYOCAMYCIN; TUBERCIDIN;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN TRANSPORT; RNA SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; HELA CELLS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TOYOCAMYCIN;

EID: 0030959931     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BORER, R.A., LEHNER, C.F., EPPENBERGER, H.M. & NIGG, E.A. (1989). Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell, 1989, 379.
2. BUSCH, H. &. SMETANA, K. (1970). The Nucleolus. Academic Press, New York.
3. CHAN, P.K. (1992). Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism). Experimental Cell Research, 203, 174.
4. CHAN, P.K., ALDRICH, M & BUSCH, H. (1985). Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation. Experimental Cell Research, 161, 101.
5. CHAN, P.K., ALDRICH, M.B. & YUNG, B.Y-M. (1987). Studies of nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells. Cancer Research, 47, 3798.
6. CHAN, P.K., ALDRICH, M B & CHAKRABARTY, S (1988). Assessment of tumor cell sensitivity to mitomycin C by 'B23 translocation' assay. Cancer Letters, 40, 143.
7. CHAN, P.K., LIU, Q.R. & DURBAN, E. (1990). The major phosphorylation site of nucleophosmin (B23) is phosphorylated by a nuclear kinase II. Biochemical Journal, 270, 549.
8. CHAN, P.K., QI, Y., AMLEY, J. & KOLLER, C.A. (1996). Quantitation of the NPM-translocation using imaging analysis. Cancer Letters, 100, 191.
9. CHAN, W.Y, LIU Q.R., BORJIGIN, J, BUSCH, H., RENNERT, O.M., TEASE, L A. & CHAN, P.K. (1989). Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry, 28, 1033.
10. CHENG, C.S., HINSHAW, B.C., PANZICA, R.P. & TOWNSEND, L.B. (1976). Synthesis of 2-amino-5-cyano-7-(β-D-ribofuranosyl)pyrrolo[2,3-D]-pyrimidin-4-one. An important precursor for the synthesis of nucleoside Q and Q*. Journal of American Chemical Society, 98, 7870.
11. CHOMCZYNSKI, P & SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156.
12. CROOKE, S.T. (1979). Biochemical effects of drugs on the cell nucleus. In: Effects of Drugs on the Cell Nucleus. Busch, H., Crooke, S.T. & Daskal, Y. (eds), p. 127. Academic Press: New York.
13. DUMBAR, T.S., GENTRY, G.A. & OLSON, M.O. (1989). Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry, 28, 9495.
14. FEUERSTEIN, N., CHAN, P.K, & MOND, J.J (1988). Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. Journal of Biological Chemistry, 263, 10608.
15. FEUERSTEIN, N., MOND, J.J., KINCHINGTON, P R., HICKEY, R., KARJALAINEN- LINDSBERG, M.L., HAY, I. & RUYECHAN, W.T. (1990). Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. Biochimica et Biophysica Acta, 1087, 127.
16. FINCH, R.A & CHAN, P.K. (1992). Studies of actinomycin D induced NPM-translocation in P388D1 cells implanted in DBA/2 mice. Oncology, 49, 223.
17. FINCH, A. R. & CHAN, P.K. (1996). ATP depletion affects NPM translocation and exportation of rRNA from nuclei. Biochemical Biophysical Research Communications, 222, 553.
18. FINCH, R.A., REVANKAR, G.R. & CHAN, P.K. (1993). Nucleolar localization of nucleophosmin/B23 requires GTP. Journal of Biological Chemistry, 268, 5823.
19. HARDESTY, C.T., CHANEY, N.A., WARAVDEKAR, V.S. & MEAD, J.A.R. (1974) The disposition of the antitumor agent, sangivamycin, in mice. Cancer Research, 34, 1005.
20. HEINE, U. (1969). Electron microscopic studies on HeLa cells exposed to the antibiotic toyocamycin. Cancer Research, 29, 1875.
21. HINSHAW, B.C., GERSTER, J.F., ROBINS, R.K. & TOWNSEND, L B (1970). Pyrrolopyrimidine nucleosides. V. A study on the relative chemical reactivity of the 5-cyano group of the nucleside antibiotic toyocamycin and desaminotoyocamycin. The synthesis of analogs of sangivamycin. Journal of Organic Chemistry, 35, 236.
22. MONNERON, A., BURGLEN, J. & BERNHARD, W. (1970). Action of toyocamycin on nucleolar fine structure and function. Journal of Ultrastructure Research, 32, 370.
23. NISHIMURA, H., KATAGIRI, K.K., SATO, K., MAYAMA, M. & SHIMAOKA, N. (1956). Toyocamycin, a new anticandida antibiotic. Journal of Antibiotics (Tokyo), 9A, 60.
24. ORRICK, L.R., OLSON, M.O.J. &. BUSCH, H (1973). Comparisons of nucleolar proteins of normal rat liver and Novikoff hepatoma ascites cells by two-dimensional polyacrylamide gel electrophoresis. Proceedings of the National Academy of Sciences (USA), 70, 1316.
25. PARKS, R.E. & BROWN, P.R. (1973) Incorporation of nucleosides into the nucleotide pools of human erythrocytes. Adenosine and its analogs. Biochemistry, 12, 3294.
26. PRESTAYKO, A.W., KLOMP, G.R., SCHMOLL, D.J. & BUSCH, H. (1974). Comparisons of proteins of ribosomal subunits and nucleolar preribosomal particles from Novikoff hepatoma ascites cells by two-dimensional polyacrylamide gel electrophoresis. Biochemistry, 13, 1945.
27. RAMASAMY, K., IMAMURA, N., ROBINS, R.K. & REVANKAR, G.R (1987). A facile synthesis of tubercidin and related 7-deazapurine nucleosides via the stereo specific sodium salt glycosylation procedure. Tetrahedron Letters, 28, 5107.
28. RAMASAMY, K., JOSHI, R.V, ROBINS, R.K. & REVANKAR, G.R (1989). Total and stereospecific synthesis of cadeguomycin, 2′-deoxy-cadeguomycin, ara-cadeguomycin, and certain related nucleosides. Journal of the Chemical Society, Perkin Transactions, 1, 2375.
29. ROBINS, R.K. & REVANKAR, G.R. (1985). Purine analogs and related nucleosides and nucleotides as antitumor agents. Medicinal Research Reviews, 5, 273.
30. SPECTOR, D.L., OCHS, R.L & BUSCH, H. (1984). Silver staining, immuno-fluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23. Chromosoma, 90, 139.
31. SWEET, P., CHAN, P.K. &. SLATER, L.M. (1989). Cyclosporin A and verapamil enhancement of daunorubicin produced nucleolar protein B23 translocation in daunorubicin resistant and sensitive tumor cells. Cancer Research, 49, 677.
32. SUHADOLNIK, R.J. (1970). Pyrrolopyrimidine nucleosides. In: Nucleoside Antibiotics, Suhadolnik, R.J. (ed.), p. 29. Wiley Interscience: New York.
33. SUHADOLNIK, R.J. (1979). Biochemical properties of toyocamycin. In: Nucleosides as Biological Probes. Suhadolnik, R.J. (ed.), p. 166. John Wiley & Son: New York.
34. SUHADOLNIK, R.J., UEMATSU, T. & UEMATSU, H. (1967). Toyocamycin: phosphorylation and incorporation into RNA and DNA and the biochemical properties of the triphosphate. Biochimica et Biophysica Acta, 149, 41.
35. TAVITIAN, A., URETSKY, S.C. & ACS, G (1968). Selective inhibition of ribosomal RNA synthesis in mammalian cells. Biochimica et Biophysica Acta, 157, 33.
36. TOLMAN, R.L., ROBINS, R.K. & TOWNSEND, L.B. (1969). Pyrrolopyrimidine nucleosides III. The total synthesis of toyocamycin, sangivamycin, tubercidin and related derivatives. Journal of the American Chemical Society, 91, 2102.
37. WEISS, J.W. & PITOT, H.C (1974) Inhibition of ribosomal RNA maturation in Novikoff hepatoma cells by toyocamycin, tubercidin, and 6-thioguanosine. Cancer Research, 34, 581.
38. YUNG, B.Y-M., BUSCH, H. & CHAN, P.K. (1985a). Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. Biochimica et Biophysica Acta, 826, 167.
39. YUNG, B Y-M., BUSCH, R.K., BUSCH, H., MAUGER, A B., & CHAN, P.K. (1985b). Effects of actinomycin D analogs on nucleolar phosphoprotein B23 (37 kD/pI 5.1). Biochemical Pharmacology, 34, 4059.